FactSet Analysts Give Teladoc Health Hold Rating and Price Target

Summary

According to a FactSet survey, analysts give Teladoc Health an average rating of ‘hold’ with an average price target of $8.97.Trading View

Impact Analysis

This event is classified at the company level as it specifically concerns Teladoc Health’s stock ratings and price targets. The ‘hold’ rating suggests a neutral outlook among analysts, reflecting cautious sentiment amid Teladoc’s strategic activities like acquisitions and compensation changes.Reuters+ 2 Analyst target price adjustments, such as those from Wells Fargo and Jefferies, indicate a lower market valuation, which may signal skepticism about Teladoc’s ability to turn around its declining revenue and stock performance after previous high-profile acquisitions like Livongo.Stock Star+ 4 This situation presents risks related to potential underperformance against these targets but also opportunities if Teladoc can successfully integrate its acquisitions and improve operational results.